There is need for alternative treatment to circumvent current treatment limitations
Iyza F. Baig
Advertisement
Articles by Iyza F. Baig
Treatment should focus on the underlying etiology behind these processes
Advertisement
Latest Updated Articles
- Exploring tocilizumab for giant cell arteritis cases
August 27th 2018
When autoimmune diseases exert neuro-ophthalmic effectsSeptember 25th 2018
Considering use of teprotumumab in thyroid eye disease patientsOctober 22nd 2018
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
iOpeners with Nicole Bajic, MD: Nikolina Budimlija, MD, on building a multidisciplinary dry eye clinic in Ireland
4
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
5